XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock
Capital Surplus [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Deferred Benefits for Directors [Member]
Beginning Balance at Dec. 31, 2021 $ 2,693,166 $ 144,484 $ 141,834 $ 1,635,642 $ 977,765 $ (199,759) $ (5,120) $ (1,680)
Beginning Balance, shares at Dec. 31, 2021     62,307,245          
Net income 44,124       44,124      
Other comprehensive income (loss) (106,192)           (106,192)  
Comprehensive income (loss) (62,068)              
Common dividends declared (20,538)       (20,538)      
Preferred dividends declared (2,531)       (2,531)      
Stock issued for dividend reinvestment         (505) 505    
Stock issued for dividend reinvestment, shares     14,531          
Treasury shares acquired (62,323)         (62,323)    
Treasury shares acquired, shares     (1,724,571)          
Stock options exercised 373     (192)   565    
Stock options exercised, shares     16,209          
Stock compensation expense 1,241     1,241        
Deferred benefits for directors- net (4)     14       (18)
Ending Balance at Mar. 31, 2022 2,547,316 144,484 $ 141,834 1,636,705 998,315 (261,012) (111,312) (1,698)
Ending Balance, shares at Mar. 31, 2022     60,613,414          
Beginning Balance at Dec. 31, 2022 2,426,662 144,484 $ 141,834 1,635,877 1,077,675 (308,964) (262,416) (1,828)
Beginning Balance, shares at Dec. 31, 2022     59,198,963          
Net income 42,341       42,341      
Other comprehensive income (loss) 28,017           28,017  
Comprehensive income (loss) 70,358              
Common dividends declared (20,561)       (20,561)      
Preferred dividends declared (2,531)       (2,531)      
Treasury shares acquired (52)         (52)    
Treasury shares acquired, shares     (1,394)          
Stock options exercised 103     (34)   137    
Stock options exercised, shares     4,441          
Restricted stock granted       (1,372)   1,372    
Restricted stock granted, shares     44,559          
Stock compensation expense 1,585     1,585        
Deferred benefits for directors- net (107)     5       (112)
Ending Balance at Mar. 31, 2023 $ 2,475,457 $ 144,484 $ 141,834 $ 1,636,061 $ 1,096,924 $ (307,507) $ (234,399) $ (1,940)
Ending Balance, shares at Mar. 31, 2023     59,246,569